Bruker Co. (NASDAQ:BRKR) Stake Increased by Sequoia Financial Advisors LLC

Sequoia Financial Advisors LLC raised its stake in shares of Bruker Co. (NASDAQ:BRKR) by 3.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 34,172 shares of the medical research company’s stock after acquiring an additional 1,251 shares during the quarter. Sequoia Financial Advisors LLC’s holdings in Bruker were worth $2,360,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in BRKR. First Horizon Advisors Inc. raised its stake in shares of Bruker by 120.4% in the 2nd quarter. First Horizon Advisors Inc. now owns 399 shares of the medical research company’s stock valued at $25,000 after purchasing an additional 218 shares in the last quarter. Covestor Ltd raised its stake in Bruker by 139.1% during the first quarter. Covestor Ltd now owns 361 shares of the medical research company’s stock valued at $34,000 after buying an additional 210 shares in the last quarter. UMB Bank n.a. lifted its holdings in Bruker by 115.3% during the 3rd quarter. UMB Bank n.a. now owns 661 shares of the medical research company’s stock worth $46,000 after buying an additional 354 shares during the last quarter. Gordian Capital Singapore Pte Ltd acquired a new position in shares of Bruker in the 2nd quarter worth approximately $52,000. Finally, GAMMA Investing LLC increased its holdings in shares of Bruker by 81.0% in the 3rd quarter. GAMMA Investing LLC now owns 867 shares of the medical research company’s stock valued at $60,000 after acquiring an additional 388 shares during the last quarter. 79.52% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on BRKR shares. Wells Fargo & Company assumed coverage on shares of Bruker in a report on Tuesday, August 27th. They issued an “overweight” rating and a $78.00 price objective for the company. The Goldman Sachs Group lowered their price objective on shares of Bruker from $72.00 to $60.00 and set a “sell” rating for the company in a research report on Tuesday, July 9th. Citigroup cut their target price on shares of Bruker from $95.00 to $80.00 and set a “buy” rating on the stock in a report on Wednesday, July 10th. Barclays began coverage on Bruker in a report on Tuesday, October 15th. They set an “overweight” rating and a $75.00 target price for the company. Finally, TD Cowen cut their price target on Bruker from $74.00 to $72.00 and set a “hold” rating on the stock in a report on Wednesday, August 7th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and seven have issued a buy rating to the stock. According to MarketBeat.com, Bruker presently has a consensus rating of “Moderate Buy” and a consensus target price of $80.82.

Bruker Trading Down 2.2 %

Shares of BRKR stock opened at $58.39 on Friday. Bruker Co. has a 1 year low of $53.79 and a 1 year high of $94.86. The firm has a market capitalization of $8.49 billion, a PE ratio of 21.23, a price-to-earnings-growth ratio of 2.52 and a beta of 1.18. The stock has a fifty day moving average of $64.98 and a two-hundred day moving average of $68.32. The company has a debt-to-equity ratio of 1.18, a quick ratio of 0.75 and a current ratio of 1.65.

Bruker (NASDAQ:BRKR) last posted its quarterly earnings data on Tuesday, August 6th. The medical research company reported $0.52 earnings per share for the quarter, hitting the consensus estimate of $0.52. The business had revenue of $800.70 million during the quarter, compared to the consensus estimate of $799.44 million. Bruker had a net margin of 11.29% and a return on equity of 24.92%. The company’s quarterly revenue was up 17.4% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.50 earnings per share. As a group, research analysts expect that Bruker Co. will post 2.61 EPS for the current year.

Bruker Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, September 16th. Investors of record on Monday, September 2nd were paid a dividend of $0.05 per share. The ex-dividend date of this dividend was Friday, August 30th. This represents a $0.20 dividend on an annualized basis and a dividend yield of 0.34%. Bruker’s dividend payout ratio is presently 7.27%.

Bruker Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.